高雄醫學大學圖書館 |

語系/ Language: 繁體中文

登入

回首頁

Identification of Therapeutics for P...

Morales Vasquez, Desarey,

Identification of Therapeutics for Public Health Emergent Viruses: Zika Virus and Severe Acute Respiratory Syndrome Coronavirus 2 /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Identification of Therapeutics for Public Health Emergent Viruses: Zika Virus and Severe Acute Respiratory Syndrome Coronavirus 2 // Desarey Morales Vasquez.
作者:	Morales Vasquez, Desarey,
面頁冊數:	1 electronic resource (183 pages)
附註:	Source: Dissertations Abstracts International, Volume: 86-02, Section: B.
提要註:	The emergence of viral outbreaks has posed a great human threat and severely affected communities, public health infrastructures, and economies globally. In the last 20 years, the world has been hit by several and significant viral diseases, including the 2003 outbreak of severe acute respiratory syndrome coronavirus (SARS-CoV), the 2009 outbreak of H1N1 influenza virus, the 2012 outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV), the 2015 outbreak of Zika virus (ZIKV), the 2020 outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the 2022 outbreak of monkeypox virus (MPOX). These outbreaks caused severe damage overall to the countries affected but more importantly, they also demonstrated how unprepared the world is for these emerging pathogens. Despite efforts, the prophylactics and therapeutics developed to combat these viruses were not effective and/or long lasting, urging to identify better approaches. In this dissertation, the goal was to utilize drug repurposing, e.g. drugs already approved or studied for the treatment of a new disease, as an approach to identify broad-spectrum antivirals that could be used against emerging viral infections. This is possible due to the target of the compound being a host factor that is required by different viruses to replicate. While identifying therapeutics against ZIKV, SARS-CoV-2 emerged so we applied our expertise in drug discovery to identify therapeutics against SARS-CoV-2 . Utilizing compounds from ReFRAME and NPC libraries, we were able to identify inhibitors against ZIKV and SARS-CoV-2.
Contained By:	Dissertations Abstracts International86-02B.
標題:	Immunology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31299908
ISBN:	9798383683750

Identification of Therapeutics for Public Health Emergent Viruses: Zika Virus and Severe Acute Respiratory Syndrome Coronavirus 2 /
Morales Vasquez, Desarey,

Identification of Therapeutics for Public Health Emergent Viruses: Zika Virus and Severe Acute Respiratory Syndrome Coronavirus 2 /Desarey Morales Vasquez. - 1 electronic resource (183 pages)

Source: Dissertations Abstracts International, Volume: 86-02, Section: B.

The emergence of viral outbreaks has posed a great human threat and severely affected communities, public health infrastructures, and economies globally. In the last 20 years, the world has been hit by several and significant viral diseases, including the 2003 outbreak of severe acute respiratory syndrome coronavirus (SARS-CoV), the 2009 outbreak of H1N1 influenza virus, the 2012 outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV), the 2015 outbreak of Zika virus (ZIKV), the 2020 outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the 2022 outbreak of monkeypox virus (MPOX). These outbreaks caused severe damage overall to the countries affected but more importantly, they also demonstrated how unprepared the world is for these emerging pathogens. Despite efforts, the prophylactics and therapeutics developed to combat these viruses were not effective and/or long lasting, urging to identify better approaches. In this dissertation, the goal was to utilize drug repurposing, e.g. drugs already approved or studied for the treatment of a new disease, as an approach to identify broad-spectrum antivirals that could be used against emerging viral infections. This is possible due to the target of the compound being a host factor that is required by different viruses to replicate. While identifying therapeutics against ZIKV, SARS-CoV-2 emerged so we applied our expertise in drug discovery to identify therapeutics against SARS-CoV-2 . Utilizing compounds from ReFRAME and NPC libraries, we were able to identify inhibitors against ZIKV and SARS-CoV-2.

English

ISBN: 9798383683750Subjects--Topical Terms:

187040
Immunology.
Subjects--Index Terms:

Public health emergence

Identification of Therapeutics for Public Health Emergent Viruses: Zika Virus and Severe Acute Respiratory Syndrome Coronavirus 2 /
LDR:03319nam a22004693i 4500 001 391441
005 20251124054757.5
006 m o d
007 cr|nu||||||||
008 251208s2024 miu||||||m |||||||eng d
020 $a 9798383683750
035 $a (MiAaPQD)AAI31299908
035 $a AAI31299908
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Morales Vasquez, Desarey, $e author. $0 (orcid)0000-0002-7357-9821 $3 523923
245 1 0 $a Identification of Therapeutics for Public Health Emergent Viruses: Zika Virus and Severe Acute Respiratory Syndrome Coronavirus 2 / $c Desarey Morales Vasquez.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 1 electronic resource (183 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-02, Section: B.
500 $a Advisors: Martinez-Sobrido, Luis Committee members: Torrelles, Jordi B.; Dye, Timothy D.; Anderson, Timothy J. C.; Patterson, Jean L.
502 $b Ph.D. $c The University of Texas Health Science Center at San Antonio $d 2024.
520 $a The emergence of viral outbreaks has posed a great human threat and severely affected communities, public health infrastructures, and economies globally. In the last 20 years, the world has been hit by several and significant viral diseases, including the 2003 outbreak of severe acute respiratory syndrome coronavirus (SARS-CoV), the 2009 outbreak of H1N1 influenza virus, the 2012 outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV), the 2015 outbreak of Zika virus (ZIKV), the 2020 outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the 2022 outbreak of monkeypox virus (MPOX). These outbreaks caused severe damage overall to the countries affected but more importantly, they also demonstrated how unprepared the world is for these emerging pathogens. Despite efforts, the prophylactics and therapeutics developed to combat these viruses were not effective and/or long lasting, urging to identify better approaches. In this dissertation, the goal was to utilize drug repurposing, e.g. drugs already approved or studied for the treatment of a new disease, as an approach to identify broad-spectrum antivirals that could be used against emerging viral infections. This is possible due to the target of the compound being a host factor that is required by different viruses to replicate. While identifying therapeutics against ZIKV, SARS-CoV-2 emerged so we applied our expertise in drug discovery to identify therapeutics against SARS-CoV-2 . Utilizing compounds from ReFRAME and NPC libraries, we were able to identify inhibitors against ZIKV and SARS-CoV-2.
546 $a English
590 $a School code: 0853
650 4 $2 96060 $a Immunology. $3 187040
650 4 $2 96060 $a Pharmacology. $3 185640
650 4 $2 96060 $a Public health. $3 206087
650 4 $2 96060 $a Microbiology. $3 187154
650 4 $2 96060 $a Virology. $3 187922
653 $a Public health emergence
653 $a Repurposing
653 $a Severe acute respiratory syndrome coronavirus 2
653 $a Screening
653 $a Therapeutics
653 $a Zika virus
690 $a 0720
690 $a 0982
690 $a 0410
690 $a 0419
690 $a 0573
710 2 $a The University of Texas Health Science Center at San Antonio. $b Molecular Medicine. $e degree granting institution. $3 523924
720 1 $a Martinez-Sobrido, Luis $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-02B.
790 $a 0853
791 $a Ph.D.
792 $a 2024
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31299908

筆 0 讀者評論

多媒體

評論

新增評論分享你的心得，請勿在此評論區張貼涉及人身攻擊、情緒謾罵、或內容涉及非法的不當言論，館方有權利刪除任何違反評論規則之發言，情節嚴重者一律停權，以維護所有讀者的自由言論空間。

Export

取書館別